National Immunobiological Company is a pharmaceutical holding founded by the state corporation Rostec in 2013 to support the development and production of immunobiological medicines vital to national security. The company brings together leading Russian biopharmaceutical manufacturers, including NPO Microgen and FORT.
Nacimbio's operations cover the full cycle — from research and development to production and distribution — of vaccines and toxoids included in the current and future National Immunization Schedule, as well as blood products, bacteriophages, allergens, botulinum toxin type A, and other biologics.